New ACC/AHA Hypertrophic Cardiomyopathy Guideline Encourages Shared Decision-Making
The new 2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients with Hypertrophic Cardiomyopathy, published in the Journal of the American College of Cardiology, offers recommendations on the evaluation and management of patients with HCM, encourages shared decision-making between the clinician and patient when determining treatment course, and updates recommendations for sudden cardiac death risk assessment and HCM center referrals based on the latest evidence. Read more. To accompany the guideline, the College has developed several tools and resources including a clinician-focused HCM Guidelines Made Simple Tool and a patient-focused CardioSmart HCM Infographic. In addition, don't miss an interactive central illustration in JACC and two HCM Guideline-focused case reports in the latest issue of JACC: Case Reports from de Feria, et al., and Kantor, et al. Access these tools and more via ACC's HCM Guideline Hub.